Ottawa Hospital Research Institute

L'Institut de recherche de l'Hôpital d'Ottawa

Ottawa, Ontario

Sorting 1 by

Accepting patients

ABBV-383

A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma
Learn more
  • Bispecific Antibody
  • BCMA
  • Phase 1
  • 23-193